1. Safety and tolerability of injectable lipid-lowering drugs: an update of clinical data
   Larysa Strilchuck et al, 2019, Expert Opinion on Drug Safety CrossRef
2. Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes
   Kelly D. Myers et al, 2019, Circ: Cardiovascular Quality and Outcomes CrossRef
3. PCSK9 inhibitors for treating hypercholesterolemia
   Andrea Pasta et al, 2020, Expert Opinion on Pharmacotherapy CrossRef
4. Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9
   Klaus-Dieter Schlüter et al, 2020, Front. Physiol. CrossRef
5. Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
   Nadeem Qureshi et al, 2023, Health Technol Assess CrossRef